Regen Lab
Switzerland - Le Mont-sur-LausanneBiotechnology
Focus: Regen Lab specializes in dermal and musculoskeletal cell therapies using platelet-rich plasma (PRP) technology, operating as a focused biotechnology company since 2003. The company is headquartered in Switzerland and operates in the regenerative medicine niche.
Profile data last refreshed 2d ago · AI intelligence enriched 1w ago
Open Jobs
0
About Regen Lab
AI assessmentNot HiringNo open roles listed right now. Follow Regen Lab to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
13 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Regenkit BCT-HA Cellular Matrix
Skin WrinklingClinical Trials (1)
NCT02832583Autologous Platelet Rich Plasma Combined to Hyaluronic Acid Obtained With Regen-Kit BCT-HA in Aesthetic Medicine
N/AHelp build intelligence for Regen Lab
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.